Robert A. Jones

1.6k total citations
29 papers, 1.2k citations indexed

About

Robert A. Jones is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Robert A. Jones has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Robert A. Jones's work include Cancer Cells and Metastasis (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Cancer-related Molecular Pathways (7 papers). Robert A. Jones is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Cancer-related Molecular Pathways (7 papers). Robert A. Jones collaborates with scholars based in Canada, United States and Italy. Robert A. Jones's co-authors include Roger A. Moorehead, Alicia Viloria‐Petit, Jeff C. Liu, Eldad Zacksenhaus, Jim Petrik, Craig I. Campbell, Zhe Jiang, Aiyi Liu, Constantine Dimitrakakis and Carolyn A. Bondy and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.

In The Last Decade

Robert A. Jones

29 papers receiving 1.2k citations

Peers

Robert A. Jones
Inmaculada Ibañez de Cáceres Spain
Mauricio P. Pinto Chile
Walid J. Azar Australia
Guillermo Pita Spain
Claus Lattrich Germany
Yuanjie Niu China
Yuanjie Niu China
Craig J. Burd United States
F. Javier Carmona Spain
Ploutarchos Anezinis Greece
Inmaculada Ibañez de Cáceres Spain
Robert A. Jones
Citations per year, relative to Robert A. Jones Robert A. Jones (= 1×) peers Inmaculada Ibañez de Cáceres

Countries citing papers authored by Robert A. Jones

Since Specialization
Citations

This map shows the geographic impact of Robert A. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Jones more than expected).

Fields of papers citing papers by Robert A. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Jones. The network helps show where Robert A. Jones may publish in the future.

Co-authorship network of co-authors of Robert A. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Jones. A scholar is included among the top collaborators of Robert A. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Jones. Robert A. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Litman, Ethan, Anna M. Modest, Esther A. Bondzie, et al.. (2025). Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season. JAMA Network Open. 8(2). e2460729–e2460729. 2 indexed citations
2.
New, Laura A., Peihua Lu, Claire E. Martin, et al.. (2023). Distinct Requirements for Adaptor Proteins NCK1 and NCK2 in Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia. 28(1). 19–19. 2 indexed citations
3.
Jones, Robert A., et al.. (2018). The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC). Molecular Cancer. 17(1). 52–52. 194 indexed citations
4.
Schott, Courtney R., Robert A. Jones, Benjamin Deheshi, et al.. (2018). An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression. BMC Veterinary Research. 14(1). 365–365. 18 indexed citations
5.
Liu, Jeff C., Letizia Granieri, Mariusz Shrestha, et al.. (2018). Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer. Cell Reports. 23(1). 112–126. 60 indexed citations
6.
Watson, Katrina L., et al.. (2018). The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line. Experimental Cell Research. 369(1). 17–26. 25 indexed citations
7.
8.
Jones, Robert A., Tyler Robinson, Jeff C. Liu, et al.. (2016). RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. Journal of Clinical Investigation. 126(10). 3739–3757. 99 indexed citations
9.
Watson, Katrina L., Leanne Stalker, Robert A. Jones, & Roger A. Moorehead. (2015). High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice. BMC Cancer. 15(1). 37–37. 10 indexed citations
10.
Jones, Robert A., Katrina L. Watson, Craig I. Campbell, & Roger A. Moorehead. (2014). IGF-IR Mediated Mammary Tumorigenesis Is Enhanced during Pubertal Development. PLoS ONE. 9(9). e108781–e108781. 4 indexed citations
11.
Liu, Jeff C., Véronique Voisin, Dong‐Yu Wang, et al.. (2014). Combined deletion of P ten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on e EF 2 K. EMBO Molecular Medicine. 6(12). 1542–1560. 84 indexed citations
12.
Jiang, Zhe, Robert A. Jones, Jeff C. Liu, et al.. (2011). RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle. 10(10). 1563–1570. 82 indexed citations
13.
Jiang, Zhe, Tao Deng, Robert A. Jones, et al.. (2010). Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. Journal of Clinical Investigation. 120(9). 3296–3309. 116 indexed citations
14.
Jones, Robert A., Craig I. Campbell, Geoffrey A. Wood, Jim Petrik, & Roger A. Moorehead. (2009). Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene. 28(21). 2152–2162. 47 indexed citations
15.
Jones, Robert A., Craig I. Campbell, Jim Petrik, & Roger A. Moorehead. (2008). Characterization of a Novel Primary Mammary Tumor Cell Line Reveals that Cyclin D1 Is Regulated by the Type I Insulin-Like Growth Factor Receptor. Molecular Cancer Research. 6(5). 819–828. 17 indexed citations
16.
Jones, Robert A. & Roger A. Moorehead. (2008). The Impact of Transgenic IGF-IR Overexpression on Mammary Development and Tumorigenesis. Journal of Mammary Gland Biology and Neoplasia. 13(4). 407–413. 20 indexed citations
17.
Hardikar, Winita, Katrina J. Allen, R. Mark Wellard, et al.. (2007). Liver transplantation for argininosuccinic aciduria: Clinical, biochemical, and metabolic outcome. Liver Transplantation. 14(1). 41–45. 3 indexed citations
18.
Jones, Robert A., Craig I. Campbell, Edward J. Gunther, et al.. (2006). Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene. 26(11). 1636–1644. 108 indexed citations
19.
Jones, Robert A., et al.. (1993). Membrane localisation of a UDP-sugar hydrolase, inSalmonella, is by an uncleaved N-terminal signal peptide. FEMS Microbiology Letters. 114(3). 299–3047. 4 indexed citations
20.
Gimble, Jeffrey M., Qi Cheng, Kay L. Medina, et al.. (1990). Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: Biochemical and molecular characterization. European Journal of Immunology. 20(2). 379–387. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inmaculada Ibañez de Cáceres Breakdown of academic impact, for papers by Mauricio P. Pinto Breakdown of academic impact, for papers by Walid J. Azar Breakdown of academic impact, for papers by Guillermo Pita Breakdown of academic impact, for papers by Claus Lattrich Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Craig J. Burd Breakdown of academic impact, for papers by F. Javier Carmona Breakdown of academic impact, for papers by Ploutarchos Anezinis
Rankless by CCL
2026